Allogene Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALLO and other ETFs, options, and stocks.About ALLO
Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells.
CEODavid D. Chang
CEODavid D. Chang
Employees229
Employees229
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2017
Founded2017
Employees229
Employees229
ALLO Key Statistics
Market cap271.23M
Market cap271.23M
Price-Earnings ratio-1.01
Price-Earnings ratio-1.01
Dividend yield—
Dividend yield—
Average volume3.53M
Average volume3.53M
High today$1.35
High today$1.35
Low today$1.24
Low today$1.24
Open price$1.26
Open price$1.26
Volume3.71M
Volume3.71M
52 Week high$3.78
52 Week high$3.78
52 Week low$0.8621
52 Week low$0.8621
ALLO News
Simply Wall St 5d
Allogene Therapeutics And 2 Other Promising Penny Stocks To WatchIn the last week, the market has stayed flat, but it is up 11% over the past year with earnings expected to grow by 15% per annum in the coming years. For inves...
Analyst ratings
86%
of 14 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own ALLO. This list is generated using Robinhood data, and it’s not a recommendation.